Arterial Thrombosis

Cardiovascular
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
JETi lower extremity arterial thrombosisN/A1 trial
Active Trials
NCT04370691Completed129Est. Oct 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbottJETi lower extremity arterial thrombosis

Clinical Trials (1)

Total enrollment: 129 patients across 1 trials

NCT04370691AbbottJETi lower extremity arterial thrombosis

JETi Lower Extremity Arterial Thrombosis

Start: Mar 2020Est. completion: Oct 2024129 patients
N/ACompleted

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space